Impact of LX4211 on Cardiovascular Risk Factors in Type 2 Diabetes

Vinall, Phil
December 2012
MD Conference Express;Dec2012, p26
Academic Journal
The article discusses the results from the Safety and Efficacy of LX4211 with Metformin in T2DM Patients with Inadequate Glycemic Control on Metformin study by Julio Rosenstock. The study evaluates the dose-range efficacy and safety of LX4211 versus placebo from baseline to Week 12 in patients, 18 to 75 years old, with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin monotherapy. It reveals that LX4211 has the potential to address multiple cardiovascular disease risk factors in diabetic patients.


Related Articles

  • Self-monitoring of blood glucose was not cost-effective in non-insulin- treated type 2 diabetes. Simon, J. // Evidence Based Medicine;Dec2008, Vol. 13 Issue 6, p171 

    Design: cost-effectiveness analysis of a randomised controlled trial with 1-year follow-up (Diabetes Glycaemic Education and Monitoring [DiGEM]. Setting: 48 general practices in the UK. Patients: 453 patients {mean age 66 y, 57% men} who had non-insulin-treated type 2 diabetes with haemoglobin...

  • Knee skin pricking to monitor capillary blood glucose is less painful than finger pricking in children with type 1 diabetes. Castilla-Peón, María; Ponce-de-León-Rosales, Sergio; Calzada-León, Raúl // International Journal of Diabetes in Developing Countries;Nov2015, Vol. 35 Issue 4, p620 

    The article discusses the study which aims to identify an alternative to finger pricking for blood sugar monitoring for children with type 1 diabetes. The study reportedly involved a randomized crossover trial to examine capillary blood glucose measurements, preferred punctured sites, and pain...

  • Subcutaneous Continuous Glucose Monitoring. Jungheim, Karsten; Koschinsky, Theodor; Wientjes, Klaas-Jan; Schoonen, Adelbert J.; Heinemann, Lutz; Lodwig, Volker // Diabetes Care;Sep2001, Vol. 24 Issue 9, p1696 

    Provides information on a study which examined the feasibility of a microdialysis-based subcutaneous continuous glucose monitoring (SCGM) system for type 1 and type 2 diabetics. Elements of the SCGM system; Analysis of glucose spot-measurement schemes to detect hypoglycemic episodes; Performance...

  • Tears Tell Tale of Diabetic Blood Sugar.  // Review of Optometry;10/15/2003, Vol. 140 Issue 10, p10 

    Discusses the importance of tears in determining the amount of blood sugar in a diabetic patient. Findings of the study that compares the tear glucose level with the corresponding blood glucose levels in patients; Utilization of tears as a means to estimate blood glucose status of patients;...

  • Glycemic Variability in Patients with Type 2 Diabetes on Basal Insulin and Fixed Combination Oral Antidiabetic Treatment - Results of a Pilot Study. De Mattia, Giancarlo; Laurenti, Oriana; Moretti, Arianna; Mollica, Maria R. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA148 

    Type 2 diabetes (T2DM) is a progressive disease, which may eventually require insulin therapy when glycemic control fails using oral antidiabetic drugs (OADs) alone. Once-daily glargine ensures a 24-hr basal insulin replacement in T2DM patients, which can allow lower glycemic fluctuations during...

  • Is waist circumference a useful screening tool for diabetes mellitus in an overweight multi-ethnic population? Featherstone, John J.; Goyder, Elizabeth // Quality in Primary Care;2007, Vol. 15 Issue 3, p137 

    Background Fourteen percent of adults over 60 years may have type two diabetes mellitus, with up to half of these undiagnosed. Screening of high-risk populations is recommended by policymakers, but there is no direct evidence of benefit for those screened. Although abdominal obesity is a...

  • CoZmonitor Convenient for Treating Type 1 Kids.  // Diabetes Health;Sep2006, Vol. 15 Issue 9, p33 

    The article reports on the convenience of using the CoZmonitor blood glucose module from Smiths Medical in treating children with type 1 diabetes according to a Colorado study. The experimental group who uses the CoZmonitor blood glucose module, that attaches with the Deltec Cozmo pump and uses...

  • Measuring Glycaemic Variation. Cameron, Fergus J.; Donath, Susan M.; Baghurst, Peter A. // Current Diabetes Reviews;2010, Vol. 6 Issue 1, p17 

    The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various meetrics of GV in qualitatively different datasets. The purpose of this review is to...

  • New tool for diagnosing diabetes.  // Cortlandt Forum;Sep/Oct2008, Vol. 21 Issue 8, p7 

    The article provides information on the use of hemoglobin A[1c] (HbA[1c]) testing as a tool for diagnosing diabetes in asymptomatic but high risk adults. It states that experts on diabetes along with pathologists and internists have established that the HbA[1c] is a better diagnostic tool, which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics